Antimycobacterial activity of 2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan, entrapped in polymeric microparticles (2012)
- Authors:
- USP affiliated authors: SILVA, CELIO LOPES - FMRP ; BENTLEY, MARIA VITORIA LOPES BADRA - FCFRP ; SOARES, EDSON GARCIA - FMRP
- Unidades: FMRP; FCFRP
- DOI: 10.3109/03639045.2011.598535
- Subjects: TUBERCULOSE (TRATAMENTO); MYCOBACTERIUM TUBERCULOSIS (EFEITOS DE DROGAS); FARMACOLOGIA; MODELOS ANIMAIS DE DOENÇAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Drug Development and Industrial Pharmacy
- ISSN: 0363-9045
- Volume/Número/Paginação/Ano: v. 38, n. 3, p. 259-263, 2012
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão submetida (Pré-print)
- Acessar versão aberta:
-
ABNT
MINARINI, Paulo R. R. et al. Antimycobacterial activity of 2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan, entrapped in polymeric microparticles. Drug Development and Industrial Pharmacy, v. 38, n. 3, p. 259-263, 2012Tradução . . Disponível em: https://doi.org/10.3109/03639045.2011.598535. Acesso em: 31 mar. 2026. -
APA
Minarini, P. R. R., Souza, A. O. de, Soares, E. G., Barata, L. E. S., Silva, C. L., & Bentley, M. V. L. B. (2012). Antimycobacterial activity of 2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan, entrapped in polymeric microparticles. Drug Development and Industrial Pharmacy, 38( 3), 259-263. doi:10.3109/03639045.2011.598535 -
NLM
Minarini PRR, Souza AO de, Soares EG, Barata LES, Silva CL, Bentley MVLB. Antimycobacterial activity of 2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan, entrapped in polymeric microparticles [Internet]. Drug Development and Industrial Pharmacy. 2012 ; 38( 3): 259-263.[citado 2026 mar. 31 ] Available from: https://doi.org/10.3109/03639045.2011.598535 -
Vancouver
Minarini PRR, Souza AO de, Soares EG, Barata LES, Silva CL, Bentley MVLB. Antimycobacterial activity of 2-phenoxy-1-phenylethanone, a synthetic analogue of neolignan, entrapped in polymeric microparticles [Internet]. Drug Development and Industrial Pharmacy. 2012 ; 38( 3): 259-263.[citado 2026 mar. 31 ] Available from: https://doi.org/10.3109/03639045.2011.598535 - Experimental tuberculosis: designing a better model to test vaccines against tuberculosis
- Increased level of interferon-'gama' primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection
- Immune regulatory effect of pHSP65 DNA therapy in pulmonary tuberculosis: activation of 'CD8 POT +' cells, interferon-(gama) recovery and reduction of lung injury
- Prime-boost vaccination based on DNA and protein-loaded microspheres for tuberculosis prevention
- Liquid crystallyne systems for gene therapy, polarizing microscopic and toxicity studies
- Lipid systems monoolein-based for entrapment of protein and DNA in gene therapy
- Liquid crystallyne formulations as delivery systems for gene therapy
- Leukotrienes play an essential role in a murine moel of histoplasmosis immunity
- Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis
- Effect of DNA hsp65 vaccine in acute infection by Mycobacterium tuberculosis
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
